Home Medicine Interferences in coagulation tests – evaluation of the 570-nm method on the Dade Behring BCS analyser
Article
Licensed
Unlicensed Requires Authentication

Interferences in coagulation tests – evaluation of the 570-nm method on the Dade Behring BCS analyser

  • Ralf Junker , Margit Käse , Helmut Schulte , Ruth Bäumer , Claus Langer and Ulrike Nowak-Göttl
Published/Copyright: September 21, 2011

Abstract

The Dade Behring BCS is a coagulation analyser with optical reaction detection (standard 405nm). The present study was conducted to evaluate measurement at 570nm for analyses in interfering plasma samples. Prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen and D-dimer in normal (n=50), lipaemic (n=60), icteric (n=113), and haemolytic (n=58) samples were measured at 405 and 570nm. As they are unaffected by the optical properties of the sample, the mechanical STAcompact analyser (Roche Diagnostics) and an ELISA technique were defined as the “comparison” methods. The percentage of valid PT results using the 570-nm method varied from 54% (lipaemic samples) to 97% (haemolytic samples). Valid aPTT measurements were found in 67% (lipaemic samples) up to 93% (icteric samples) of samples. Fibrinogen measurement revealed valid results in 58% (lipaemic samples) to 100% (haemolytic samples) of samples. The number of valid D-dimer results varied from 28% (lipaemic material) up to 100% (haemolytic material). Significant inter-method differences were found: aPTT in lipaemic (BCS 405 vs. 570nm) and icteric samples (STAcompact vs. BCS 405 and 570nm); fibrinogen in lipaemic (BCS 405 vs. 570nm), icteric (BCS 405 vs. 570nm; STAcompact vs. BCS 570nm) and haemolytic samples (STAcompact vs. BCS 405 and 570nm). Differences between the BCS 570-nm and the STAcompact methods were in most cases low and less pronounced than between the BCS 570- and 405-nm methods, making the BCS 570-nm method an alternative to measurement at 405nm. Limitations have to be taken into account regarding lipaemic plasma.


Both authors contributed equally to this work; Corresponding author: Ralf Junker, MD, Abendrothsweg 31, 20251 Hamburg, Germany Phone: +49-40-46090175, Fax: +49-40-46093045,

References

1 The International Federation of Clinical Chemistry. IFCC provisional recommendation on quality control in clinical chemistry. J Clin Chem Biochem 1976;14:270–9. Search in Google Scholar

2 Guder WG, da Fonseca-Wollheim F, Heil W, Schmitt YM, Töpfer G, Wisser H, Zawta B. The haemolytic, icteric and lipaemic sample – recommendations regarding their recognition and prevention of clinically relevant interferences. J Lab Med 2000; 24: 357–64. Search in Google Scholar

3 Selby C. Interference in immunoassay. Ann Clin Biochem 1999; 36: 704–21. 10.1177/000456329903600603Search in Google Scholar

4 Berends F, Engelhardt W, Fickenscher K, Junker R, Keller F, Meyers W, et al. Multicentre evaluation of a new coagulation analyzer for coagulometric, chromogenic and immunologic tests [abstract]. Ann Hematol 1997;74(Suppl II). Search in Google Scholar

5 Grafmeyer D, Bondon M, Manchon M, Levillain P. The influence of bilirubin, haemolysis and turbidity on 20 analytical tests performed on automatic analysers. Results of an interlaboratory study. Eur J Clin Chem Clin Biochem 1995; 33: 31–52. Search in Google Scholar

6 BCS Coagulation System – Instruction Manual – Version 2.2. Marburg, Germany: Dade Behring, 2000. Search in Google Scholar

7 STAcompact – User Manual – Version 1.0b. Mannheim, Germany: Roche Diagnostics, 1996. Search in Google Scholar

8 Lammers M, Gressner AM. Immunonephelometric quantification of free haemoglobin. J Clin Chem Clin Biochem 1987; 25: 363–7. 10.1515/cclm.1987.25.6.363Search in Google Scholar

9 Dempfle CE, Zips S, Ergul H, Heene DL, Fibrin Assay Comparative Trial Study Group. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT Study Group. Thromb Haemost 2001; 85: 671–8. Search in Google Scholar

10 Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 1031–3. 10.1055/s-0038-1656098Search in Google Scholar

11 Oosting JD, Hoffmann JJ. Evaluation of an automated photometric fibrinogen assay. Blood Coagul Fibrinolysis 1997; 8: 321–6. 10.1097/00001721-199709000-00001Search in Google Scholar

12 Ermens AA, Bury JG, Wijn-Maas EC. Evaluation of an automated hemostasis testing analyzer, the Thrombolyzer Combi. Clin Lab 2000; 46: 463–7. Search in Google Scholar

13 Quehenberger P, Kapiotis S, Handler S, Ruzicka K, Speiser W. Evaluation of the automated coagulation analyzer Sysmex CA 6000. Thromb Res 1999; 96: 65–71. 10.1016/S0049-3848(99)00069-9Search in Google Scholar

Received: 2004-7-2
Accepted: 2004-12-14
Published Online: 2011-9-21
Published in Print: 2005-4-1

©2005 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Quality control for SELDI analysis
  2. Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients
  3. Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling
  4. Simultaneous determination of HIV antibodies, hepatitis C antibodies, and hepatitis B antigens in dried blood spots –a feasibility study using a multi-analyte immunoassay
  5. Hematopoietic cytokines in the sera of patients with pancreatic cancer
  6. Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells
  7. Whole genome amplification of buccal cell DNA: genotyping concordance before and after multiple displacement amplification
  8. Y-Chromosome short tandem repeat (STR) haplotypes in a Campania population sample
  9. TaqMan assays for genotyping of single nucleotide polymorphisms present at a disease susceptibility locus on chromosome 6
  10. The secretion of ibuprofen metabolites interferes with the capillary chromatography of urinary homovanillic acid and 4-hydroxy-3-methoxymandelic acid in neuroblastoma diagnosis
  11. Selective measurement of HCHO in urine using direct liquid-phase fluorimetric analysis
  12. A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes
  13. Simultaneous analysis of MDR1 C3435T, G2677T/A, and C1236T genotypes by multiplexed mutagenically separated PCR
  14. Measurement of reticulocyte and red blood cell indices in patients with iron deficiency anemia and β-thalassemia minor
  15. Chitotriosidase activity in colostrum from African and Caucasian women
  16. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation
  17. Controlled storage conditions prolong stability of biochemical components in whole blood
  18. Poor knowledge and faulty thinking regarding hemolysis and potassium elevation
  19. Delayed effects of short-term transdermal application of 7-oxo-dehydroepiandrosterone on its metabolites, some hormonal steroids and relevant proteohormones in healthy male volunteers
  20. Evaluation of a novel semi-automated HPLC procedure for whole blood cyclosporin A confirms equivalence to adjusted monoclonal values from Abbott TDx
  21. Evaluation of the Bio-Rad VARIANT™ II HbA 2/HbA 1C Dual Program for measurement of hemoglobin concentrations and detection of variants
  22. Interferences in coagulation tests – evaluation of the 570-nm method on the Dade Behring BCS analyser
  23. No evidence for involvement of the human inducible nitric oxide synthase gene in susceptibility to coronary artery disease
  24. National survey on the use of measurement of cholinesterase activity in serum
Downloaded on 30.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2005.041/pdf
Scroll to top button